The best online providers offer strong support services to help you succeed in your GLP-1 weight loss journey.

A new formulation of the best-selling cancer drug, Keytruda ... Analysts expect that Merck might be able to continue to ...

Novo Nordisk and Eli Lilly are facing scores of personal injury claims for allegedly failing to warn patients about side ...

Prosper Junior Bakiny (Eli Lilly): For those looking for top growth stocks to buy right now, it's a great time to consider investing in one of the best-performing healthcare ... The company's forward ...

Research shows that 1 in 8 adults in the US has used one of the popular GLP-1 medications, most of them trying to manage ...

A HEALTHCARE worker has told show she almost died after fat loss jabs she ordered from Facebook were feared to have been ...

Hims & Hers offers personalized telehealth services, with a stock price that reflects high-growth potential. See why we ...

The headline trial results will be closely monitored by pharmaceutical industry experts. Shares in Novo Nordisk, which ...

Obesity has been declared a disease by WHO. It is associated not only with heart disease, diabetes, stroke, gallstones, ...

Amgen refutes in a press release that its trial obesity drug, MariTide, may cause bone loss density. Amgen's stock has risen 4.6% this year against a decrease of 3.8% for the pharmaceuticals industry.

Altimmune’s lead drug Pemvidutide demonstrates significant progress in obesity and liver health. See why ALT stock is a ...